Nebraska Pharmacy Defense · NE Pharmacy Board · NE MFCU · DEA · PBM Audits

Nebraska Pharmacy Audit
& Healthcare Defense

Defense for pharmacies, providers, and healthcare companies facing PBM audits, Medicare and Medicaid investigations, DEA inquiries, and state board action.

Request a Free Case Review
Audit Hotline - Direct Line
(800) 345 - 4125
Speak with an attorney - not a call center. Immediate response.
Nebraska Pharmacy Audit & Healthcare Defense Briefing

PBM Audits and Defense Scope

Nebraska pharmacies operate under the Nebraska Board of Pharmacy (NE Pharmacy Board) for state licensure and disciplinary matters, the Nebraska Medicaid Fraud Control Unit (MFCU) for Medicaid healthcare enforcement, and the Nebraska Attorney General for state healthcare fraud matters - alongside federal frameworks (PBM, DEA, HHS-OIG, DOJ).

Health Law Alliance defends Nebraska pharmacies against PBM audits, NE Pharmacy Board inspections and disciplinary matters, MFCU investigations, DEA Order to Show Cause proceedings, and federal healthcare fraud investigations. Nebraska is among the 30+ states that have enacted PBM regulatory legislation, which adds state-law procedural protections on top of the federal framework. The defense framework starts with the Nebraska regulatory regime.

Federal regulators are increasingly delegating Medicaid enforcement to the states. State Medicaid Fraud Control Units and state Attorneys General are now the primary enforcement vector for pharmacy Medicaid claims - and have grown significantly more aggressive since 2023. The defense framework starts with the state regulatory regime.

2,500+
Clients Represented
96%
Reduction of a $4.7M OptumRx Demand
2,000+
Audits Overseen by Our Bench
Immediate
Response - Audit Notices Don't Wait
Client Reviews
What Clients Say
5.0
Full-Service Defense
Every regulatory front, one bench.

Health Law Alliance defends pharmacies, providers, and healthcare operators across the complete range of audits, investigations, and enforcement actions.

The Stakes
An audit or investigation rarely ends at the first letter

By the time the notice arrives, the downstream exposure is already stacked. Here's what you're actually defending against.

  • Six- and seven-figure recoupments
  • Network termination & credentialing loss
  • Referrals to DEA, DOJ & state boards
Pharmacy claim documentation under audit
The claim file
01
Six- and seven-figure recoupments

High-cost claims across PBM, Medicare, and Medicaid audits routinely reimburse at hundreds to thousands of dollars per fill. A 12-month look-back across hundreds of patients produces recoupment demands of $250K to $4M+, often extrapolated across your full claim population.

Financial Exposure
02
Network termination & credentialing loss

PBMs and payors increasingly use audit findings as grounds for termination for cause. That designation follows you across every network and can end your Medicare Part D, Medicaid MCO, and commercial access - often within 30 days.

Network Access
03
Referrals to DEA, DOJ & state boards

An audit finding can become a DEA, FDA, or state board matter. What begins as a billing review can become a civil investigative demand, a state board complaint, or a federal healthcare fraud investigation within weeks.

Regulatory & Criminal Risk
Why Health Law Alliance
Built by Former Prosecutors and Healthcare Executives

Four advantages that come from a bench of former payor executives, claims auditors and investigators, and federal and state prosecutors.

Factor 01
Former prosecutors.
Our bench includes a former Assistant U.S. Attorney who built and prosecuted healthcare fraud cases. We know how the government assembles a case - and how to dismantle one before it reaches indictment.
Factor 02
Former payor executives.
Our founding partner was a senior executive at UnitedHealth Group, the parent of Optum and OptumRx.
Factor 03
Statistical extrapolation expertise.
Most large recoupments rest on a sample extrapolated across your full claim population. The single biggest dollar defense is challenging the sampling methodology and error-rate calculation.
Factor 04
Multi-front coordination.
A PBM audit can spawn a DEA inquiry, an FDA matter, a state board complaint, and a federal investigation at once. We defend all fronts as one coordinated matter so a billing dispute does not become a license action.
"By the time the audit letter arrives, you have 30 days. The pharmacies that win are the ones that mobilize in the first 72 hours."
Protect Your Pharmacy Now →
Illustrative stack of legal and medical records prepared for document review
Document review · Illustrative image, not a client record
Document Review

The audit response shapes the findings and the appeal

A PBM audit runs on the deadlines in your network agreement. What you produce, and when, becomes the record the PBM uses to set findings, chargebacks, and any network action.

Notice and contract deadlineIdentify the audit type and the appeal windows the network agreement imposes.
Audit type and auditorConfirm whether the matter is a desk audit, an onsite audit, or an investigational audit, and which PBM or delegate is running it.
Claims and documentation at issueReview the claim sample and the requested records before producing a file that cannot be withdrawn.
The HLA Defense Process
A four-stage defense protocol

Our bench includes a former federal prosecutor who served as Chief Compliance Officer of UnitedHealth Group, OptumRx’s parent company.

  • Notice triage & deadline lock
  • Chart-level defense build
  • Level-1 & Level-2 appeal response
  • Litigation & regulatory containment
Conference room
Where defense is built
01
Notice triage & deadline lock

Within 24 hours: parse every deadline in the audit notice, place a litigation hold on the claims at issue, and preserve adjudication logs before the PBM rotates them out.

02
Chart-level defense build

Claim-by-claim reconstruction: prescriber PA rationale, plan criteria at time of fill, signature logs, dispensing and delivery records, and documentation. Every flagged claim gets its own defense memo.

03
Level-1 & Level-2 appeal response

We draft and file the written appeal, quantify the PBM's extrapolation errors, and negotiate directly with the auditor and network relations.

04
Litigation & regulatory containment

If the PBM refuses a reasonable resolution, we file in federal court and pair the suit with regulatory defense at DEA, FDA, and the state board - so a PBM dispute does not escalate into a license action.

Health Law Alliance attorneys
The HLA Bench

The HLA Nebraska Pharmacy Audit & Healthcare Defense Team

Health Law Alliance handles the response and any parallel appeal, licensing matter or referral as one coordinated matter, so the strategy does not change hands as the matter moves between forums.

The bench includes a former Assistant U.S. Attorney nominated for the DOJ Director's Award, senior healthcare-company counsel, and attorney-providers with experience across healthcare audits and investigations.

Health Law Alliance

Firm record

5,000+Matters handled
2,500+Clients represented
2,000+Audits overseen
ImmediateAttorney response
Former professional experience

Where Our Attorneys Served Before Health Law Alliance

Department of Justice Former Assistant U.S. Attorney
Drug Enforcement Administration Former DEA Diversion Program Manager
UnitedHealth Group Former Chief Compliance Officer
McKesson Former Chief Counsel and Vice President

Agency and company marks identify former professional experience of individual HLA team members. They do not imply affiliation, endorsement, or a client relationship.

Common Audit Triggers
Six patterns that put a pharmacy — or any healthcare business — on an auditor's list

If any of these describe your pharmacy, you are already in the audit pool - whether or not the notice has arrived.

01
High-cost drug dispensing above benchmarks.
PBM and payor analytics flag pharmacies whose high-cost drug share of revenue runs well above peer benchmarks - especially independents and small chains.
02
Telehealth prescriber concentration.
Scripts concentrated among a small set of telehealth prescribers are retrospectively scrutinized for prior-auth validity and patient-prescriber continuity.
03
Out-of-state dispensing patterns.
High percentages of out-of-state shipments - common in compounding and mail-order models - trigger both PBM and state board review.
04
Compounded drug claims.
Billing compounded medications to a commercial plan or federal program draws heightened PBM, FDA, and state board scrutiny.
05
Documentation or signature-log gaps.
Even a single sampled fill with a missing signature log, prior-auth record, or supporting chart note can be extrapolated across the full look-back period.
06
Prior complaints or probation with the state board.
Pharmacies with any open or recent state board matter are prioritized for PBM audits - because the PBM can rely on the state's record as corroborating exposure.
Recent Outcomes
Representative Case Results

Outcomes are summarized for confidentiality. Client names, precise geography, and identifying facts are redacted.

Case files Recoupment Reversed
OptumRx Audit - $4.7M Demand Reduced to $180K

OptumRx full-scope audit across three fill years on high-cost specialty medications.

PBM Audit · 2024

Attorney advertising. Prior results do not guarantee a similar outcome. Case summaries are generalized for confidentiality and are not a substitute for legal advice on your specific audit.

Audit & Investigation FAQ
Frequently Asked Questions

Seven questions that come up on almost every first call.

I just received an audit notice. How long do I have? +
The written response window is typically 30 days from the date on the notice, but document-production deadlines inside the notice are often shorter - sometimes as little as 10 business days. The first 72 hours are the most important: preserve the flagged claims' adjudication logs, identify every prescriber of record, and put a litigation hold in place. Missing the production deadline can waive your ability to appeal on the merits.
How do PBMs and payors pick which pharmacies to audit? +
Analytics first, complaints second. PBM and payor data teams rank pharmacies by high-cost drug share of revenue, telehealth prescriber concentration, out-of-state dispensing percentage, and compounded-medication billing. A pharmacy in the top decile on any two of those metrics has a meaningfully elevated audit probability regardless of actual compliance posture.
My claims had approved prior auths. Can the PBM still recoup? +
Yes - and this is the single most misunderstood part of pharmacy audits. PBMs are invoking contractual "right to audit" provisions to re-review previously approved PAs against the plan's clinical criteria in force at the time of fill. The defense is to pull the PBM's own adjudication rationale and the plan's published criteria for that dispense date. An approved PA is evidence, not a safe harbor, but it's strong evidence when defended properly.
What about compounded medications? Is there any defense? +
Yes, and it's fact-specific. Compounding during an FDA-declared shortage operates under 503A / 503B pathways that PBMs routinely mis-apply post hoc. The defense looks at shortage status on the dispense date, the prescriber's documented medical-necessity rationale, USP 797 compliance, and state board posture. Compounded-medication matters typically need coordinated PBM, DEA / FDA, and state board defense - which is our core practice.
Will engaging counsel make the PBM more aggressive? +
In our experience, the opposite. PBM audit teams close matters faster - and at much lower recoupment figures - when the pharmacy is represented by counsel with a track record of federal litigation. Audit teams recognize when a file is being defended on a path to federal court versus processed like a typical pharmacy response, and the settlement posture changes accordingly.
What does HLA cost, and how is the engagement structured? +
We scope each matter individually. A typical audit defense is a flat-fee engagement tied to the phase of work (notice response, appeal, litigation), so you know your exposure upfront. For pharmacies facing potential termination, we offer expedited emergency engagement. Every engagement starts with a free, privileged consultation - no retainer required.
I haven't been audited yet, but I'm worried. Is it too early to call? +
No - it's the right time. Proactive review is dramatically cheaper than reactive defense. We offer a compliance review where our team samples your highest-risk claims against current PBM and payor criteria, identifies the fills most likely to be flagged, and helps you remediate documentation gaps before a notice arrives.
Speak with an Attorney Today

Get a free, privileged review of your matter before you respond

Before you write a single page of your written response, have a privileged conversation with attorneys who have overseen 2,000+ audits - from both sides of the table. Free, confidential, no retainer.

Under audit or investigation? Every day costs leverage.